Study: Antibiotic use in moderate COVID-19 linked to clinica

Antibiotic treatment of adults hospitalized with moderate COVID-19 is associated with clinical deterioration, despite the drugs being given to over 40% of patients, according to new research being presented at this year's ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April)

Related Keywords

Germany , Barcelona , Comunidad Autonoma De Cataluna , Spain , Anette Friedrichs , Escmid Global Congress , Global Congress , German National Pandemic Cohort Network , University Hospital Schleswig Holstein , Progression Scale , Antibiotic , Covid 19 , Antimicrobial Resistance , Bacteria , Iagnostics , Drugs , Hospital , Pandemic , Pneumonia , Public Health , Research , Espiratory , Cars , Ars Cov 2 ,